{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:40:35Z","timestamp":1789609235054,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T00:00:00Z","timestamp":1541203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12886-018-0948-2","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T09:21:32Z","timestamp":1541236892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Cancer-associated retinopathy preceding the diagnosis of cancer"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2521-1333","authenticated-orcid":false,"given":"Florence","family":"Hoogewoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Butori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Blanche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine P.","family":"Br\u00e9zin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,3]]},"reference":[{"key":"948_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0039-6257(02)00416-2","volume":"48","author":"JW Chan","year":"2003","unstructured":"Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol. 2003;48:12\u201338.","journal-title":"Surv Ophthalmol"},{"key":"948_CR2","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/0002-9394(76)90125-2","volume":"81","author":"RA Sawyer","year":"1976","unstructured":"Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol. 1976;81:606\u201313.","journal-title":"Am J Ophthalmol"},{"key":"948_CR3","first-page":"355","volume":"4","author":"CL Scott","year":"1997","unstructured":"Scott CL, Cher LM, O\u2019Day J. Cancer associated retinopathy and non-small cell lung cancer. J Clin Neurosci Off J Neurosurg Soc Australas. 1997;4:355\u20137.","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"948_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0002-9394(02)01598-2","volume":"134","author":"H Katsuta","year":"2002","unstructured":"Katsuta H, Okada M, Nakauchi T, Takahashi Y, Yamao S, Uchida S. Cancer-associated retinopathy associated with invasive thymoma. Am J Ophthalmol. 2002;134:383\u20139.","journal-title":"Am J Ophthalmol"},{"key":"948_CR5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.ajo.2004.01.010","volume":"137","author":"H Ohguro","year":"2004","unstructured":"Ohguro H, Yokoi Y, Ohguro I, Mamiya K, Ishikawa F, Yamazaki H, et al. Clinical and immunologic aspects of cancer-associated retinopathy. Am J Ophthalmol. 2004;137:1117\u20139.","journal-title":"Am J Ophthalmol"},{"key":"948_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/BF00165939","volume":"230","author":"Y Matsui","year":"1992","unstructured":"Matsui Y, Mehta MC, Katsumi O, Brodie SE, Hirose T. Electrophysiological findings in paraneoplastic retinopathy. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch F\u00fcr Klin Exp Ophthalmol. 1992;230:324\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch F\u00fcr Klin Exp Ophthalmol"},{"key":"948_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10633-011-9277-y","volume":"123","author":"A Anastasakis","year":"2011","unstructured":"Anastasakis A, Dick AD, Damato EM, Spry PG, Majid MA. Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction. Doc Ophthalmol Adv Ophthalmol. 2011;123:59\u201363.","journal-title":"Doc Ophthalmol Adv Ophthalmol"},{"key":"948_CR8","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1167\/iovs.13-11868","volume":"54","author":"Y Makiyama","year":"2013","unstructured":"Makiyama Y, Kikuchi T, Otani A, Oishi A, Guo C, Nakagawa S, et al. Clinical and immunological characterization of paraneoplastic retinopathy. Invest Ophthalmol Vis Sci. 2013;54:5424\u201331.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"948_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1136\/bjophthalmol-2012-302524","volume":"97","author":"KL Pepple","year":"2013","unstructured":"Pepple KL, Cusick M, Jaffe GJ, Mruthyunjaya P. SD-OCT and autofluorescence characteristics of autoimmune retinopathy. Br J Ophthalmol. 2013;97:139\u201344.","journal-title":"Br J Ophthalmol"},{"key":"948_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s10384-006-0396-z","volume":"51","author":"A Oohira","year":"2007","unstructured":"Oohira A. Fifteen-year follow-up of patient with cancer-associated retinopathy. Jpn J Ophthalmol. 2007;51:74\u20135.","journal-title":"Jpn J Ophthalmol"},{"key":"948_CR11","first-page":"251","volume":"116","author":"G Adamus","year":"1998","unstructured":"Adamus G, Amundson D, MacKay C, Gouras P. Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy. Arch Ophthalmol Chic Ill 1960. 1998;116:251\u20133.","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"948_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1006\/jaut.1998.0221","volume":"11","author":"G Adamus","year":"1998","unstructured":"Adamus G, Machnicki M, Elerding H, Sugden B, Blocker YS, Fox DA. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun. 1998;11:523\u201333.","journal-title":"J Autoimmun"},{"key":"948_CR13","first-page":"885","volume":"12","author":"A Maeda","year":"2006","unstructured":"Maeda A, Maeda T, Liang Y, Yenerel M, Saperstein DA. Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen. Mol Vis. 2006;12:885\u201391.","journal-title":"Mol Vis"},{"key":"948_CR14","doi-asserted-by":"publisher","first-page":"e0167909","DOI":"10.1371\/journal.pone.0167909","volume":"11","author":"JC Ten Berge","year":"2016","unstructured":"Ten Berge JC, van Rosmalen J, Vermeer J, Hellstr\u00f6m C, Lindskog C, Nilsson P, et al. Serum autoantibody profiling of patients with paraneoplastic and non-paraneoplastic autoimmune retinopathy. PLoS One. 2016;11:e0167909.","journal-title":"PLoS One"},{"key":"948_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/jamaophthalmol.2013.574","volume":"131","author":"S Faez","year":"2013","unstructured":"Faez S, Loewenstein J, Sobrin L. Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy. JAMA Ophthalmol. 2013;131:113\u20135.","journal-title":"JAMA Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-018-0948-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-018-0948-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-018-0948-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T20:10:57Z","timestamp":1572725457000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-018-0948-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,3]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["948"],"URL":"https:\/\/doi.org\/10.1186\/s12886-018-0948-2","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,3]]},"assertion":[{"value":"19 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approved in writing by the Ethics Committee of the French Society of Ophthalmology (IRB 00008855 Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Ophtalmologie IRB#1).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"285"}}